MicroBiome Bank Standardized Fecal Microbiota Transplant Platform Launches: FMT Goes Industrial
MicroBiome Bank establishes the world's first standardized FMT donor database and preparation process, elevating fecal transplant quality control to pharmaceutical grade.
MicroBiome Bank Standardized Fecal Microbiota Transplant Platform Launches
On October 3, 2028, American nonprofit OpenBiome and Johnson & Johnson's Janssen jointly launched MicroBiome Bank, the world's first standardized fecal microbiota transplant (FMT) platform. The platform established a database of 5,000 rigorously screened donors and GMP-compliant fecal microbiota preparation processes, elevating FMT quality control from laboratory to pharmaceutical grade.
MicroBiome Bank's preparation process includes four stages: donor screening (covering 200 pathogens), microbiota isolation and purification, lyophilization, and quality testing. Each batch includes a complete microbiota composition analysis report and quality certificate.
OpenBiome executive director Carolyn Edelstein states that FMT has proven 90% efficacy against recurrent Clostridioides difficile infection, but previous preparation processes lacked standardization with significant batch-to-batch microbiota composition variation. MicroBiome Bank solves this, making FMT a truly reproducible standardized therapy.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.